Respiratory syncytial virus is the second most common cause of infant mortality and a major
cause of morbidity and mortality in older adults (aged> 60 years). Efforts to develop a …

Background Respiratory syncytial virus (RSV)‐associated acute respiratory infection (ARI) is
an underrecognized cause of illness in older adults. We conducted a systematic literature …

Background Respiratory syncytial virus (RSV) infection causes considerable illness in older
adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein–based …

Background Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality
among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized …

The large global burden of respiratory syncytial virus (RSV) respiratory tract infections in
young children and older adults has gained increased recognition in recent years. Recent …

Background Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants.
The burden of RSV infection in healthy term infants has not yet been established. Accurate …

Background Adult respiratory syncytial virus (RSV) vaccines are in the late stages of
development. A comprehensive synthesis of adult RSV burden is needed to inform public …

Background Most observational population-based studies identify respiratory syncytial virus
(RSV) by nasal/nasopharyngeal swab reverse transcriptase real-time PCR (RT-PCR) only …

Background Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract
infections in adults that can result in hospitalizations. Estimating RSV-associated …

Importance Little is known about the burden and outcomes of respiratory syncytial virus
(RSV)–positive acute respiratory infection (ARI) in community-dwelling older adults …